<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03551769</url>
  </required_header>
  <id_info>
    <org_study_id>AC-18-016_FE</org_study_id>
    <nct_id>NCT03551769</nct_id>
  </id_info>
  <brief_title>Pharmacokinetics of Tricaprilin Including Food Effect on Ketone Body Production</brief_title>
  <official_title>A Phase I, Open-label, Fixed-order, Single-dose, 2-Part, Crossover Study to Evaluate the Pharmacokinetics of a Formulation of Tricaprilin (AC-SD-01) Including the Effect of Food on Ketone Body Production in Caucasians and Asians</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cerecin</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cerecin</source>
  <oversight_info>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a Phase I, single center, open label, fixed-order, crossover, food-effect,
      pharmacokinetic (PK) study recruiting healthy, adult, male subjects.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 5, 2018</start_date>
  <completion_date type="Actual">August 27, 2018</completion_date>
  <primary_completion_date type="Actual">August 16, 2018</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total ketones</measure>
    <time_frame>1 day</time_frame>
    <description>Area Under the Curve (AUC) AUC 0-last</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Total ketones</measure>
    <time_frame>1 day</time_frame>
    <description>AUC 0 - 4</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Total ketones</measure>
    <time_frame>1 day</time_frame>
    <description>AUC 0 - 6</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Total ketones</measure>
    <time_frame>1 day</time_frame>
    <description>AUC 0-8</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Total ketones</measure>
    <time_frame>1 day</time_frame>
    <description>Maximum Plasma Concentration (Cmax)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>B-hydrodxybutyrate</measure>
    <time_frame>1 day</time_frame>
    <description>AUC 0-last</description>
  </primary_outcome>
  <primary_outcome>
    <measure>B-hydroxybutyrate</measure>
    <time_frame>1 day</time_frame>
    <description>AUC 0-4</description>
  </primary_outcome>
  <primary_outcome>
    <measure>B-hydroxybutyrate</measure>
    <time_frame>1 day</time_frame>
    <description>AUC 0-6</description>
  </primary_outcome>
  <primary_outcome>
    <measure>B-hydroxybutyrate</measure>
    <time_frame>1 day</time_frame>
    <description>AUC 0-8</description>
  </primary_outcome>
  <primary_outcome>
    <measure>B-hydroxybutyrate</measure>
    <time_frame>1 day</time_frame>
    <description>Cmax</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Acetoacetate</measure>
    <time_frame>1 day</time_frame>
    <description>AUC 0-last</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Acetoacetate</measure>
    <time_frame>1 day</time_frame>
    <description>AUC 0-4</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Acetoacetate</measure>
    <time_frame>1 day</time_frame>
    <description>AUC 0-6</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Acetoacetate</measure>
    <time_frame>1 day</time_frame>
    <description>AUC 0-8</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Acetoacetate</measure>
    <time_frame>1 day</time_frame>
    <description>Cmax</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>tricaprilin</measure>
    <time_frame>1 day</time_frame>
    <description>AUC 0 - last</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>tricaprilin</measure>
    <time_frame>1 day</time_frame>
    <description>AUC 0 - 4</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>tricaprilin</measure>
    <time_frame>1 day</time_frame>
    <description>AUC 0 - 6</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>tricaprilin</measure>
    <time_frame>1 day</time_frame>
    <description>AUC 0 - 8</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>tricaprilin</measure>
    <time_frame>1 day</time_frame>
    <description>Time to maximum concentration (Tmax)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>tricaprilin</measure>
    <time_frame>1 day</time_frame>
    <description>Cmax</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>octanoic acid</measure>
    <time_frame>1 day</time_frame>
    <description>AUC 0 - last</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>octanoic acid</measure>
    <time_frame>1 day</time_frame>
    <description>AUC 0 - 4</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>octanoic acid</measure>
    <time_frame>1 day</time_frame>
    <description>AUC 0 - 6</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>octanoic acid</measure>
    <time_frame>1 day</time_frame>
    <description>AUC 0 - 8</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>octanoic acid</measure>
    <time_frame>1 day</time_frame>
    <description>Tmax</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>octanoic acid</measure>
    <time_frame>1 day</time_frame>
    <description>Cmax</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Computerized Cognitive Battery - Attention</measure>
    <time_frame>1 day</time_frame>
    <description>Rapid Visual Information Processing Test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Computerized Cognitive Battery - Episodic Memory</measure>
    <time_frame>1 day</time_frame>
    <description>Paired Associates Learning Test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Computerized Cognitive Battery - Working Memory</measure>
    <time_frame>1 day</time_frame>
    <description>Spatial Working Memory Test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Computerized Cognitive Battery - Psychomotor Function</measure>
    <time_frame>1 day</time_frame>
    <description>Reaction Time Test</description>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Alzheimer Disease</condition>
  <arm_group>
    <arm_group_label>Cohort 1, Period 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Study drug administered concurrently with a standard meal</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cohort 1, Period 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Study drug administered 30 minutes after a standard meal</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cohort 1, Period 3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Study drug administered 30 minutes after a high-fat meal</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cohort 1, Period 4</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Study drug administered after an overnight fast</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cohort 2, Period 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Study drug administered 30 minutes after a standard meal (Asian)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cohort 2, Period 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Study drug administered after an overnight fast (Asian)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>tricaprilin</intervention_name>
    <description>Tricaprilin formulated as AC-SD-01</description>
    <arm_group_label>Cohort 1, Period 1</arm_group_label>
    <arm_group_label>Cohort 1, Period 2</arm_group_label>
    <arm_group_label>Cohort 1, Period 3</arm_group_label>
    <arm_group_label>Cohort 1, Period 4</arm_group_label>
    <arm_group_label>Cohort 2, Period 1</arm_group_label>
    <arm_group_label>Cohort 2, Period 2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>standard meal</intervention_name>
    <description>standard meal</description>
    <arm_group_label>Cohort 1, Period 1</arm_group_label>
    <arm_group_label>Cohort 1, Period 2</arm_group_label>
    <arm_group_label>Cohort 2, Period 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>high-fat meal</intervention_name>
    <description>high-fat meal</description>
    <arm_group_label>Cohort 1, Period 3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>overnight fast</intervention_name>
    <description>fasting for at least 9 hours</description>
    <arm_group_label>Cohort 2, Period 2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy adult male, ages 18 - 55

          -  Able to consume a regular diet and one high fat meal; no specific dietary requirements

          -  Cohort 2 (Asian subject population) restricted to being of Japanese or Chinese
             heritage

        Exclusion Criteria:

          -  Presence of any illness or condition that, in the opinion of the investigator might
             confound the study results or poses risk to the subject

          -  Has been on a ketogenic diet as supported by review of a food diary

          -  Has positive Urine Drug Screen or alcohol results at Screening
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Nucleus Network</name>
      <address>
        <city>Melbourne</city>
        <state>Victoria</state>
        <zip>3004</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Australia</country>
  </location_countries>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>May 17, 2018</study_first_submitted>
  <study_first_submitted_qc>May 29, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 11, 2018</study_first_posted>
  <last_update_submitted>May 27, 2019</last_update_submitted>
  <last_update_submitted_qc>May 27, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 29, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alzheimer Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

